Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04TPC
|
|||
| Former ID |
DNC008932
|
|||
| Drug Name |
4-benzyl-2,6-diisobutylamino-pyrimidine
|
|||
| Synonyms |
CHEMBL493703; 4-benzyl-2,6-diisobutylamino-pyrimidine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H29N5
|
|||
| Canonical SMILES |
CC(C)CNC1=NC(=NC(=C1)NCC2=CC=CC=C2)NCC(C)C
|
|||
| InChI |
1S/C19H29N5/c1-14(2)11-20-17-10-18(21-13-16-8-6-5-7-9-16)24-19(23-17)22-12-15(3)4/h5-10,14-15H,11-13H2,1-4H3,(H3,20,21,22,23,24)
|
|||
| InChIKey |
ZOQDUFOUNDLFCC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding. J Med Chem. 2008 Oct 23;51(20):6512-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.